baber/WOPTO huggingface dataset:
Patent BR-122020002127-B1 (BR)
Title: Método e dispositivo de derivação de valores de modo de predição de referência e codificação e decodificação de informação representando modos de predição, e meio de armazenamento
Inventor: EDOUARD FRANÇOIS
IPC: H04N19/463
Filed: 2012-09-12
Abstract: Os valores de modo de predição de referência, também chamados de modos mais prováveis ou MPMs, utilizados para codificação ou decodificação de um modo de predição relacionado a uma unidade de codificação atual, são derivados. Primeiro e segundo valores de modo de predição de referência são derivados (S402) a partir de respectivos modos de predição de ao menos duas unidades de codificação vizinhas da unidade de codificação atual. O primeiro e o segundo modo de predição de refe-rência são diferentes entre si. Um terceiro valor de modo de predição de referência é derivado (S403) a partir do primeiro e do segundo valor de modo de predição de re-ferência. O terceiro modo de predição de referência é diferente de cada um dentre o primeiro e o segundo valor de modo de predição de referência. Ao derivar três MPMs ao invés de dois para comparação com o modo de predição do bloco de codificação atual, a eficiência da codificação é aprimorada. Isso ocorre devido ao aumento na probabilidade de que o modo de predição do bloco de codificação atual corresponda a um dos modos mais prováveis derivados.
Patent BR-122020012406-B1 (BR)
Title: Aparelho de transmissão, e aparelho receptor
Inventor: BAE JAE-HYEON
IPC: H04L27/26
Filed: 2016-02-15
Abstract: um aparelho de transmissão é fornecido. o aparelho de transmissão inclui: um gerador de quadro configurado para gerar um quadro incluindo uma pluralidade de símbolos de multiplexação de divisão de frequência ortogonal (ofdm); e um insersor de intervalo de guarda (gi) configurado para inserir gis no quadro gerado, em que a pluralidade de símbolos ofdm são divididos em um bootstrap, um preâmbulo e uma carga útil, e o insersor de gi insere primeiros gis tendo um tamanho correspondendo a um primeiro tamanho de transformada rápida de fourier (fft) de cada um dos símbolos ofdm configurando a carga útil nas extremidades frontais de cada um dos símbolos ofdm, insere segundos gis tendo um tamanho correspondendo a um quociente obtido pela divisão de uma região extra da carga útil calculada baseada no tamanho fft dos símbolos ofdm configurando a carga útil, o número de símbolos ofdm, e o tamanho dos primeiros gis pelo número de símbolos ofdm nas extremidades frontais de cada um dos primeiros gis, e insere um sufixo cíclico (cp) tendo um tamanho correspondendo ao restante permanecendo após dividir a região extra da carga útil pelo número de símbolos ofdm em uma extremidade traseira de um símbolo de ofdm final configurando a carga útil
Patent CS-268807-B2 (CS)
Title: Colour contact lens and method of its production
Inventor: LOSHAEK SAMUEL
IPC: C08J7/043
Filed: 1986-01-03
Abstract: Colored contact lenses are produced by providing a contact lens constructed of polymer and coating at least a portion of the lens with coloring substance and binding polymer. The lens and binding polymers are bonded to each other by the reaction of functional groups selected from at least one of -COOH, -OH, and -NH-R, wherein R is hydrogen or alkyl, with functional groups selected from at least one of -NCO and epoxy.
Patent JP-H075474-B2 (JP)
IPC: A61K47/48
Filed: 1986-01-04
Abstract: A polymeric drug comprising an inert synthetic polymeric carrier combined through aminoacid or peptide spacers with a bioactive molecule, a targeting moiety, and an optional cross-linkage, comprises:(a) 5.0 to 99.7 mol % of units derived from N-(2-hydroxypropyl) methacrylamide,(b) 0.2 to 20.0 mol % of units derived from an N-methacryloylated peptide, the peptide groups being bound to a bioactive moiety,(c) 0.1 to 94.8 mol % of units derived from N-methacrylamide, N-methacrylic acid or an N-meth- ecryloylated aminoacid or peptide, to which are bound a determinant capable of interacting with specific receptors on cell surfaces,(d) optionally, 0 to 5 mol % of units derived from an N-methacryloylated peptide, the peptide groups being bound to a linking group which is similarly attached to a similar peptide group attached to another polymer chain, and(e) optionally, as a bioassay label, Q to 2 mol % of units derived from N-methacryloylated tyrosinamide.
Patent CS-253748-B2 (CS)
Title: Fungicide and process for preparing active compound
Inventor: KARBACH STEFAN
IPC: A01N43/653
Filed: 1986-03-26
Abstract: Compounds of the formula <IMAGE> in which R, Hal and Z, which are as defined in the description, and their preparation are described. The compounds are suitable for use as fungicides.
Patent CS-200517-B2 (CS)
Title: Process for preparing derivatives of androstan-17-one or androsten-17-one
Inventor: WEBER ALFRED
IPC: A61K31/568
Filed: 1977-07-13
Abstract: The side chains of sterols are degraded by fermentation with microorganisms capable of doing so in an improved manner by employing in such fermentations sterol derivatives of the formula   <IMAGE> wherein n is 1 or 2; R1 is H or lower alkyl, R2 is alkyl, whose chain optionally is interrupted by an oxygen atom, or when n is 2, also a hydrogen atom; and R3 is a sterol side chain.
Patent CS-208459-B2 (CS)
Title: Insecticide means
Inventor: FANCHER LLEWELLYN W
IPC: A01N57/08
Filed: 1979-10-01
Abstract: "Pyrazole phosphates and phosphonates, preparation thereof and use thereof as insecticides". 
     A compound corresponding to the following general formula:
     wherein
     X represents oxygen or sulphur;   R represents C 1 -C 6  alkyl or C 1 -C 6  alkoxy;   R 1  represents C 1 -C 6  alkoxy;   R 2  represents hydrogen or methyl; and   R 3  represents hydrogen, methyl or phenyl; is disclosed.   
     Such a compound may be prepared by reacting an appropriate pyrazole with an appropriate phosphoric or phosphonic acid. 
     The present invention also relates to an insecticidal composition comprising such a compound and an agronomically acceptable carrier or diluent, and to a method of controlling insects comprising applying such a compound or such a composition to the insects and/or to the habitats thereof and or to the feedstuffs thereof.
Patent CS-202041-B2 (CS)
Title: Regulation facility for the injection pumps
Inventor: HAUBENHOFER MAXIMILIAN
IPC: F02D1/06
Filed: 1975-10-20
Abstract: 1522178 Fuel supply control in supercharged IC engines FRIEDMANN & MAIER AG 27 Oct 1975 [8 Nov 1974] 44014/75 Heading F1B A control rod (49) limiting stop device for an I.C. engine fuel injection pump includes a stop member 68 acting upon a detent 75 to limit the fuel quantity delivered to the engine, the stop member having at least two stop faces 73, 74 alternately engageable with the detent 75 so that more fuel may be delivered to the engine during starting than during other running conditions. The stop member 68 is shifted longitudinally by an intake manifold vacuum sensitive diaphragm 79 (as is conventional) but is rotated to present either stop face 73 or 74 to the detent 75 by an electromagnet 100 via a crank (not shown).
Patent JP-2789905-B2 (JP)
IPC: B62D7/14
Filed: 1992-01-10
Granted: 1998-08-27
Abstract: PURPOSE:To provide a vehicle behavior control apparatus capable of securing the continuity of the behavior control and less subjected to failure and having good responsiveness by causing an auxiliary steer control and a right/left-wheel brake force difference control to be always performed in parallel and causing the share proportion between both the controls to be appropriate. CONSTITUTION:An auxiliary steer angle calculation means determines an auxiliary steer angle for obtaining a behaviour target value while, on the other hand, a feedback control quantity calculation means determines an auxiliary steer angle correction quantity and right/left wheel brake force difference for zeroing a deviation between an actual behavior and the target value. An auxiliary steer means auxiliarily steers the vehicle wheels by a sum of the auxiliary steer angle and a correction quantity therefor while a brake force difference control means realizes the right/left wheel brake force difference. Note that suitable upper limit values are set respectively to the auxiliary steer angle correction quantity and the right/left wheel brake force difference in corresponding relation to shared proportions. The feedback control calculation means is determined to have a feedback control gain so that, when the behavior deviation reaches a set value, the auxiliary steer angle correction quantity and the right/left wheel brake force difference may simultaneously become the upper limit values, respectively.
Patent JP-2664506-B2 (JP)
IPC: F28D20/00
Filed: 1990-01-11
Granted: 1997-10-15
Abstract: Device for producing cold and/or heat by a solid gas reaction comprising a first and a second reactor each of which contains a salt capable of reacting by absorption with a gas by an exothermic reaction, the first reactor being in communication in a first operating stage with an enclosure intended to retain the gas, the second reactor being in communication, in the first operating stage, with an enclosure intended to release the gas, according to the invention, each reactor comprises a different salt. A device comprising four reactors provided with three different salts is also described.
Patent JP-4058119-B2 (JP)
IPC: A61J1/05
Filed: 1996-01-16
Granted: 2008-03-05
Abstract: It has a bottom container (1) and a top container, which has a flap (9) provided with retaining means of the bottom container. In the top container there is a tubular sleeve (15) finished in a truncated-cone-shaped portion (20) that seals by a cap (13) provided with a safety seal (14), so that after breaking the seal the cap (23) may be screwed on by partially breaking the bottom (28) of the top container, carrying out the mixing of the substances. It is characterized in that the flap has two ring-shaped ribs (10) and a stria (11) that is complemented with both annular edges (3 and 4), both having a stria, of the bottom container (1), obtaining nonrotating, leakproof and damage-proof coupling. The tubular sleeve (15) has a helicoidal edge (17) that provides a partial gentle cutting of the bottom (28). The outlet hole (21) of the medicine dropper is slightly truncated-cone-shaped facilitating the insertion of a hollow cylindrical center pin (32) provided for in the cap. The safety seal (24) includes a series of flexible wings (26) that bend in the sealing operating preventing deformation of the seal (24). <IMAGE>   <IMAGE>
Patent AU-560164-B2 (AU)
Title: Borated lube oil additive
Inventor: ANDERSON RONALD LESLIE
IPC: C07F5/04
Filed: 1983-03-18
Granted: 1987-04-02
Abstract: Borated reaction product of a long-chain aliphatic succinic acid compound and alkylene diamine having an average of at least about 2 N-substituted hydroxyalkyl-groups.
Patent AU-660456-B2 (AU)
Title: Testing implants
Inventor: CAWLEY PETER
IPC: A61F2/46
Filed: 1992-04-13
Granted: 1995-06-29
Abstract: PCT No. PCT/GB92/00663 Sec. 371 Date Oct. 28, 1993 Sec. 102(e) Date Oct. 28, 1993 PCT Filed Apr. 13, 1992 PCT Pub. No. WO92/18053 PCT Pub. Date Oct. 29, 1992.Method and apparatus for testing an implant attached to a bone of a human or animal subject includes a member releasably attached to the implant. The member carries a transducer for exciting the member with a variable frequency AC signal, and a transducer for detecting a resonance frequency of the member. The detected resonance frequency is used to assess the degree of attachment of the implant to the bone.
Patent AU-656370-B2 (AU)
Title: Electrical connector
Inventor: WALDOCK KEVIN HUNTER
IPC: F42D1/04
Filed: 1992-04-01
Granted: 1995-02-02
Abstract: An electrical connector (10) in which an electrical time dalay circuit means (64) is mounted within a connector (10) to allow a remote location of said time delay circuit means. The connector (10) also includes setting recess means (28A, 28B) within the connector (10) to produce a setting action between electrical leads (A, B) and a C-clip terminal (18) having angled tips (20A, 20B) which wedge against an inserted lead (A, B).
Patent AU-730999-B2 (AU)
Title: Genes and gene products related to Werner's syndrome
Inventor: OSHIMA JUNKO
IPC: C12N15/09
Filed: 1996-12-30
Granted: 2001-03-22
Abstract: The present invention discloses antibodies that specifically bind to a WRN gene product or a portion thereof.
Patent AU-702853-B2 (AU)
Title: Acoustic system for bone-fracture therapy
Inventor: WINDER ALAN A
IPC: A61H23/02
Filed: 1995-02-17
Granted: 1999-03-04
Abstract: A transducer for non-invasive transcutaneous transmission of pulsed ultrahigh-frequency acoustic radiation, in body tissue and/or fluids adjacent a bone fracture is "on target" when a fraction of the propagated energy within the longitudinal-response lobe of the transducer encounters a crack or other open feature of the fracture, where a gap or space exists between closely spaced fracture walls. The ultrahigh-frequency acoustic radiation sees this "on target" feature as the entrance to a waveguide, whereby pulsed ultrahigh-frequency acoustic radiation is guided within the crack. When this acoustic radiation encounters a gap of at least a quarter wavelength (at the ultrahigh frequency), a standing wave condition establishes itself, with dissipation of the ultrahigh frequency and with demodulation to establish a therapeutically beneficial low-frequency acoustic condition, within the fracture, and acting where most needed, namely, on and between wall regions of adjacent fragments of the broken bone. Collagen, callus and cartilage development is accelerated, closing the gap in a matter of days, so that thereafter zone-flooding of shear waves from transducer radiation can be osteogenically operative upon both bone fragments of the fracture and on the collagen through which they are united at first tentatively and then increasingly more securely as treatment continues, from day to day, as with one or more single treatments of 20 minutes per day.
Patent AU-612164-B2 (AU)
Title: Caustic-stable modified polycarboxylate
Inventor: BORSETH DONALD
IPC: C08F20/04
Filed: 1988-07-27
Granted: 1991-07-04
Abstract: A surfactant-modified polymer characterized in that it comprises a polycarboxylate backbone and at least 0.5 percent by weight nonionic surfactant chemically associated therewith, the surfactant-modified polymer being formed by the polymerization of a reactant compound selected from carboxylic acids, polycarboxylic acids and mixtures thereof in an aqueous media in the presence of a nonionic surfactant is disclosed.
Patent AU-692873-B2 (AU)
Title: Apparatus and method for separation of contaminants floating on the surface of a liquid
Inventor: FORSEY RICHARD JOHN
IPC: E02B15/10
Filed: 1995-05-24
Granted: 1998-06-18
Abstract: PCT No. PCT/GB95/01187 Sec. 371 Date Nov. 15, 1996 Sec. 102(e) Date Nov. 15, 1996 PCT Filed May 24, 1995 PCT Pub. No. WO95/32154 PCT Pub. Date Nov. 30, 1995An apparatus for use in the separation of a floating contaminant from a body of liquid has a rectangular planar sheet with upright wall members on each of two opposed edges and has on one of its other edges an inlet manifold. The inlet manifold has a slot aperture through which is directed a high velocity film of liquid over the sheet. The sheet has at the edge remote from the manifold a collecting device. The sheet is positioned in the liquid so that the film of liquid entrains the floating contaminants and carries them to the collecting device.
Patent AU-780771-B2 (AU)
Title: Novel sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using them
Inventor: ARONHIME JUDITH
IPC: C07C211/42
Filed: 2000-12-21
Granted: 2005-04-14
Abstract: The present invention is directed to novel polymorphic Forms XI, XII, XIII, XIV, XV and XVI of sertraline hydrochloride, to processes for preparing them, methods of using them to treat disease, methods of using them to make other sertraline hydrochloride forms, and to pharmaceutical dosages containing the novel forms.
Patent AU-776559-B2 (AU)
Title: Systems and methods for establishing a diagnostic transmission mode and communicating over the same
Inventor: KRINSKY DAVID M
IPC: H04L69/40
Filed: 2001-01-08
Granted: 2004-09-16
Abstract: Upon detection of a trigger, such as the exceeding of an error threshold or the direction of a user, a diagnostic link system enters a diagnostic information transmission mode. This diagnostic information transmission mode allows for two modems to exchange diagnostic and/or test information that may not otherwise be exchangeable during normal communication. The diagnostic information transmission mode is initiated by transmitting an initiate diagnostic link mode message to a receiving modem accompanied by a cyclic redundancy check (CRC). The receiving modem determines, based on the CRC, if a robust communications channel is present. If a robust communications channel is present, the two modems can initiate exchange of the diagnostic and/or test information. Otherwise, the transmission power of the transmitting modem is increased and the initiate diagnostic link mode message re-transmitted to the receiving modem until the CRC is determined to be correct.
Patent AU-727609-B2 (AU)
Title: Fructan- and/or polydextrose-containing dairy powders, process for preparing same and their use
Inventor: BOOTEN KARL
IPC: A23L33/26
Filed: 1997-07-17
Granted: 2000-12-14
Abstract: The present invention relates to fructan- and/or polydextrose-containing dairy powders. These powders are obtained by co-drying of the dairy and at least one ingredient selected from the group consisting of linear fructans, branched fructans, modified fructans and polydextrose. These powders improve the mouthfeel, texture and taste of the food compositions wherein they are used.
Patent AU-703756-B2 (AU)
Title: Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
Inventor: CAI XIONG
IPC: A61K31/341
Filed: 1995-06-27
Granted: 1999-04-01
Abstract: Tetrahydrofurans, tetrahydrothiophenes, pyrrolidines and cyclopentanes are disclosed that reduce the chemotaxis and respiratory burst leading to the formation of damaging oxygen radicals of polymorphonuclear leukocytes during an inflammatory or immune response. The compounds exhibit this biological activity by acting as PAF receptor antagonists, by inhibiting the enzyme 5-lipoxygenase, or by exhibiting dual activity, i.e., by acting as both a PAF receptor antagonist and inhibitor of 5-lipoxygenase. It has been determined that 5-lipoxygenase activity, oral availability, and stability in vivo (for example, glucuronidation rate) can vary significantly among the optical isomers of the disclosed compounds.
Patent AU-723458-B2 (AU)
Title: Biodegradable polyester and natural polymer compositions and films therefrom
Inventor: XU WAYNE
IPC: C08L3/02
Filed: 1997-05-13
Granted: 2000-08-24
Abstract: Biodegradable films include two biodegradable components. One component preferably is starch while the other component is a water insoluble, synthetic polymer, preferably a hydroxy-functional polyester.
Patent AU-726284-B2 (AU)
Title: A package with a closing device
Inventor: LUNDIN LARS
IPC: B65D43/22
Filed: 1997-06-06
Granted: 2000-11-02
Abstract: PCT No. PCT/SE97/00996 Sec. 371 Date Jan. 15, 1999 Sec. 102(e) Date Jan. 15, 1999 PCT Filed Jun. 6, 1997 PCT Pub. No. WO98/02364 PCT Pub. Date Jan. 22, 1998A packaging unit includes an article supporting surface (1) which is joined to a cupped lid (2, 3) on two mutually opposing side-edges via respective, generally parallel fold lines (4, 5). The article supporting surface (1) and the lids (2, 3) together form an article enclosure. A unit closure means (22, 32) is provided for holding the packaging unit in a closed state. The two lids (2, 3) have end-walls (21, 31) and the end-walls at at least one end of the packaging unit lie adjacent one another and essentially in contact with each other when the packaging unit is closed. The unit closure means includes a groove (32) in one end-wall (31) of one lid (3), and a rib (22) in that end-wall (21) of the other lid (2) that lies adjacent the groove-containing end-wall when the packaging unit is closed, such that the rib (22) engages the groove (32) in the closed state of the packaging unit, and the rib (22) and groove (32) respectively extend from the free edge (23, 33) of their respective end-walls and have a generally straight longitudinal extension.
Patent AU-618997-B2 (AU)
Title: Pharmaceutical compositions with anti-cancer activity and method for the treatment of cancer
Inventor: LARSEN ROLF OLAV
IPC: A61K33/243
Filed: 1989-04-05
Granted: 1992-01-16
Abstract: Anti-cancer platinum complexes such as cisplatin exhibit a synergistically higher level of anti-tumour activity when administered substantially simultaneously either with L-ascorbic acid, or with 5,6-O-benzylidene-L-ascorbic acid or deuterated forms thereof.
Patent AU-618801-B2 (AU)
Title: Mold assembly, and methods of mounting and removing insert thereof, and ejecting the insert
Inventor: NAKAGAWA TATSUZI
IPC: B29C45/56
Filed: 1989-04-27
Granted: 1992-01-09
Abstract: This invention relates to a mold assembly, a method of mounting and removing an insert or inserts thereof and a method of ejecting. The insert or inserts for molding a molded surface or surfaces of a molded piece or pieces are movable in a direction perpendicular to a parting line. By this movement, the insert or inserts are inserted into an insert coupling portion or portions or removed therefrom. A device for clamping and moving the insert is combined with a device for ejecting the molded piece out of the mold.
Patent AU-753969-B2 (AU)
Title: Shearable screw
Inventor: HARDT FALK
IPC: H01R4/30
Filed: 1999-07-07
Granted: 2002-10-31
Abstract: The bolt has several thread sections (3) and a head section (5). This is connected to the threaded sections via a first preferred breakage point (7), and further preferred breakage points (9) between the thread sections, in the form of cross-sectional narrowings. The breaking torque both increases and decreases from the furthest thread section to the head section, so that at least one staged preferred breakage point is formed.
Patent AU-763007-B2 (AU)
Title: Retroviral delivery system
Inventor: MITRAPHANOUS KYRIACOS ANDREOU
IPC: A61K48/00
Filed: 1999-05-21
Granted: 2003-07-10
Abstract: A retroviral delivery system capable of transducing a target site is described. The retroviral delivery system comprises a first nucleotide sequence coding for at least a pan of an envelope protein; and one or more other nucleotide sequences derivable from a retrovirus that ensure transduction of the target site by the retroviral delivery system; wherein the first nucleotide sequence is heterologous with respect to at least one of the other nucleotide sequences; and wherein the first nucleotide sequence codes for at least a part of a rabies G protein or a mutant, variant, derivative or fragment thereof that is capable or recognising the target site.
Patent AU-664899-B2 (AU)
Title: A nozzle
Inventor: EADES ANDREW
IPC: B01F5/02
Filed: 1993-05-25
Granted: 1995-12-07
Abstract: The invention relates to apparatus (1) for distributing a gas in a liquid, particularly for "floating" particulate matter from raw or flocculated sewage, comprising an inlet (2) for a gas entrained in a liquid carrier such as recycled sewage, a sinuous part (16, 18) of a flow path (3) through the apparatus, and a downstream outlet (4, 11) of substantially uniform cross section adapted to allow gas to be released from the liquid carrier and to be dispersed laterally of the flow path (3).